Impaired CaV1.2 inactivation reduces the efficacy of calcium channel blockers in the treatment of LQT8

Bamgboye, MA; Traficante, MK; Owoyemi, J; DiSilvestre, D; Vieira, DCO; Dick, IE

Dick, IE (通讯作者),Univ Maryland, Sch Med, Baltimore, MD 21210 USA.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022; 173 (): 92

Abstract

Mutations in the CaV1.2 L-type calcium channel can cause a profound form of long-QT syndrome known as longQT type 8 (LQT8), which results in cardiac a......

Full Text Link